Amilasan, Jubaira M.
HRN: 23-29-18 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/06/2023
CEFUROXIME 500MG (TAB)
07/06/2023
07/13/2023
ORAL
500 Mg
Bid
Incomplete Abortion
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes